The Bioconjugation Market is witnessing strong growth momentum as advancements in biotechnology and precision medicine continue to reshape modern healthcare. Valued at USD 5,122.32 million in 2023, the market is projected to expand at a robust CAGR of 15.2% from 2024 to 2032. Increasing adoption of targeted drug delivery systems, antibody-drug conjugates (ADCs), and personalized therapeutics is...